4-hydroxycyclophosphamide has been researched along with melphalan in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Averette, HE; Donato, D; Nguyen, HN; Penalver, M; Perras, J; Sevin, BU | 1 |
| Gebhart, E; Herrera, LA; Ostrosky-Wegman, P; Tittelbach, H | 1 |
| Ara, G; Bunnell, C; Elias, A; Frei, E; Richardson, P; Teicher, B; Tew, K; Wheeler, C | 1 |
3 other study(ies) available for 4-hydroxycyclophosphamide and melphalan
| Article | Year |
|---|---|
The use of ATP bioluminescence assays in selecting a drug screen panel for chemosensitivity testing of uterine cancer cell lines.
Topics: Adenocarcinoma; Adenosine Triphosphate; Alkaloids; Antineoplastic Agents; Cisplatin; Cyclophosphamide; Drug Screening Assays, Antitumor; Endometrial Neoplasms; Female; Humans; Intercalating Agents; Kinetics; Luminescent Measurements; Melphalan; Mitomycin; Tumor Cells, Cultured; Uterine Neoplasms | 1992 |
Changes in the proliferation of human lymphocytes induced by several cytostatics and revealed by the premature chromosome condensation technique.
Topics: Cell Cycle; Cell Fusion; Cell Line; Cells, Cultured; Chromosomes; Cisplatin; Cyclophosphamide; Humans; Lymphocyte Activation; Lymphocytes; Melphalan; Mitomycin; Mitomycins; Phytohemagglutinins | 1991 |
Double high-dose chemotherapy with stem cell rescue (HD-SCR) in patients with breast cancer - effect of sequence.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Breast Neoplasms; Carmustine; Cell Survival; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Hematopoietic Stem Cell Transplantation; Humans; Mechlorethamine; Melphalan; Mice; Neoplasms, Experimental; Tumor Cells, Cultured | 2000 |